Midodrine helps cirrhotic patients live longer, data show

08/8/2011 | Medscape (free registration)

Long-term treatment with midodrine in addition to standard medical care increased survival and improved ascites control for cirrhotic patients in a pilot study of 40 patients reported in the Journal of Hepatology. Patients in the treatment group had increases in average arterial pressure, urinary volume and urine sodium excretion, and demonstrated a drop in plasma renin activity and plasma aldosterone concentrations.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN